Exploration of the mechanism of Lithospermum erythrorhizon oil in treating atopic dermatitis based on network pharmacology and experimental validation of the PI3K-Akt pathway regulation.

Hu W, Wang Y, Zhou Y, Shi J, Li Z, Jiang X, Wu Q, Zhong C, Weng H, Ouyang S, Jing Y, Cai X, Ye M, Huang N

Open source

DOI
10.1016/j.heliyon.2025.e41707
Published
2025 Jan 30
Container
Heliyon
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.heliyon.2025.e41707,
  title = {Exploration of the mechanism of Lithospermum erythrorhizon oil in treating atopic dermatitis based on network pharmacology and experimental validation of the PI3K-Akt pathway regulation.},
  author = {Hu W and Wang Y and Zhou Y and Shi J and Li Z and Jiang X and Wu Q and Zhong C and Weng H and Ouyang S and Jing Y and Cai X and Ye M and Huang N},
  year = {2025},
  journal = {Heliyon},
  doi = {10.1016/j.heliyon.2025.e41707},
  url = {https://doi.org/10.1016/j.heliyon.2025.e41707}
}

RIS

TY  - JOUR
TI  - Exploration of the mechanism of Lithospermum erythrorhizon oil in treating atopic dermatitis based on network pharmacology and experimental validation of the PI3K-Akt pathway regulation.
AU  - Hu W
AU  - Wang Y
AU  - Zhou Y
AU  - Shi J
AU  - Li Z
AU  - Jiang X
AU  - Wu Q
AU  - Zhong C
AU  - Weng H
AU  - Ouyang S
AU  - Jing Y
AU  - Cai X
AU  - Ye M
AU  - Huang N
PY  - 2025
JO  - Heliyon
DO  - 10.1016/j.heliyon.2025.e41707
UR  - https://doi.org/10.1016/j.heliyon.2025.e41707
ER  - 

APA

W, H., Y, W., Y, Z., J, S., Z, L., X, J., Q, W., C, Z., H, W., S, O., Y, J., X, C., M, Y., & N, H. (2025). Exploration of the mechanism of Lithospermum erythrorhizon oil in treating atopic dermatitis based on network pharmacology and experimental validation of the PI3K-Akt pathway regulation.. Heliyon. https://doi.org/10.1016/j.heliyon.2025.e41707

Source records